MARSHALL WACE, LLP

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in VYGR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$487,976

+$42,884 QoQ

Shares Held

139,422

+191.6% QoQ

Ownership

0.226%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 135 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. VYGR ranks #218 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$487,976	139,422	+191.6%	Shares	Other	2026-08-13
2024-03-31	$445,092	47,808	-36.0%	Shares	Other	2024-05-15
2023-12-31	$630,830	74,743	-64.2%	Shares	Other	2024-02-14
2023-09-30	$1,616,354	208,562	-55.6%	Shares	Other	2023-11-14
2023-06-30	$5,373,220	469,277	+600.4%	Shares	Other	2023-08-14
2023-03-31	$516,546	66,997	-64.7%	Shares	Other	2023-05-15
2022-09-30	$1,123,236	189,736	-37.9%	Shares	Other	2022-11-14
2022-03-31	$2,327,490	305,445	-30.9%	Shares	Other	2022-05-16
2021-12-31	$1,197,497	441,881	+1922.2%	Shares	Other	2022-02-14
2021-06-30	$90,248	21,852	-33.2%	Shares	Sole	2021-08-13
2021-03-31	$153,993	32,695	-65.9%	Shares	Sole	2021-05-17
2020-06-30	$1,210,939	95,954	-50.7%	Shares	Sole	2020-08-13
2020-03-31	$1,779,162	194,444	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.